To verify the above hypothesis, we used acetylcysteine (NAC), an inhibitor of cellular ROS, to construct functional recovery models in ccRCC cells with stably NUDT1 knocked down (Figure 4A). This evidence concerns the gene NUDT1 and nonpapillary renal cell carcinoma.